查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1239491

按类型、移动性、组件、应用划分的医疗外骨骼（医疗外骨骼）市场：2021-2031 年全球机会分析和行业预测

Medical Exoskeleton Market By Type, By Mobility, By Component, By Application : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 264 Pages | 商品交期: 2-3个工作天内

价格

2021年全球医用外骨骼（medical exoskeletons）市场价值2.325亿美元，2022-2031年復合年增长率为29.4%，到2031年增长预计将达到美国2018 年为 30.447 亿美元。

医用外骨骼是一种可穿戴机电设备，开发为外部框架，可穿戴在患者体内以从损伤中恢復并增强生物能力，例如用于步行康復和运动支持的假肢设备。 所以这个框架给你的四肢额外的运动、力量和耐力。 医用外骨骼用于支持患有各种疾病的残疾人、残疾人和弱势群体，包括脊髓损伤 (SCI)、神经系统疾病、中风和其他创伤以及脑瘫。 这些医用外骨骼通常用于有监督的环境，例如在医务人员监督下的医院和康復中心。

医用外骨骼市场的增长是由各种医用外骨骼设备的技术进步以及脊髓损伤、多发性硬化症和帕金森病等神经系统疾病患病率上升的驱动力推动的。我来了。 此外，越来越多的残疾人士预计将推动对医用外骨骼的需求并促进市场增长。 例如，世界卫生组织 (WHO) 报告称，到 2022 年 12 月，估计将有 13 亿人（占全球人口的 16%）出现严重残疾。 由于神经系统疾病的流行和人口老龄化，这一数字正在增加。 此外，越来越多的人患有脊髓损伤、多发性硬化症和帕金森病等神经系统疾病，据信这会增加对医疗外骨骼设备的需求并推动市场增长。 例如，根据国家脊髓损伤模型系统数据库 (NSCMSD)，2022 年 6 月，据报导约有 51,000 人患有脊髓损伤。

内容

第一章介绍

第 2 章执行摘要

第 3 章市场概述

  • 市场定义和范围
  • 主要发现
    • 主要影响因素
    • 主要投资领域
  • 波特的五力分析
    • 供应商的议价能力
    • 买家的议价能力
    • 替代品的威胁很大
    • 新进入者的威胁很大
    • 竞争激烈
  • 市场动态
    • 司机
      • 神经病患病率增加
      • 脊髓损伤和脑损伤的数量增加
      • 不断增长的老年人口
    • 约束因素
      • 获得外骨骼医疗用途批准的监管挑战
    • 机会
      • 产品批准数量的增加：按市场参与者
      • 关键策略采用率的增加：按市场参与者
  • 分析 COVID-19 对市场的影响

第 4 章医疗外骨骼市场：按类型

  • 概览
    • 市场规模和预测
  • 动力外骨骼
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 被动外骨骼
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类

第 5 章医疗外骨骼市场：按移动性

  • 概览
    • 市场规模和预测
  • 文具
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 手机
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类

第 6 章医疗外骨骼市场：按组件分类

  • 概览
    • 市场规模和预测
  • 硬件
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 软件
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类

第 7 章医疗外骨骼市场：按应用

  • 概览
    • 市场规模和预测
  • 脊髓损伤
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 中风
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 其他
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类

第 8 章医疗外骨骼市场：按地区

  • 概览
    • 市场规模和预测：按地区
  • 北美
    • 主要趋势和机会
    • 市场规模和按类型预测
    • 市场规模和移动性预测
    • 各组成部分的市场规模和预测
    • 市场规模和应用预测
    • 市场规模和预测：按国家/地区分类
      • 美国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测
      • 加拿大
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测
      • 墨西哥
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测
  • 欧洲
    • 主要趋势和机会
    • 市场规模和按类型预测
    • 市场规模和移动性预测
    • 各组成部分的市场规模和预测
    • 市场规模和应用预测
    • 市场规模和预测：按国家/地区分类
      • 德国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测
      • 法国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测
      • 英国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测
      • 意大利
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测
      • 西班牙
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测
      • 其他欧洲
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测
  • 亚太地区
    • 主要趋势和机会
    • 市场规模和按类型预测
    • 市场规模和移动性预测
    • 各组成部分的市场规模和预测
    • 市场规模和应用预测
    • 市场规模和预测：按国家/地区分类
      • 日本
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测
      • 中国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测
      • 印度
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测
      • 澳大利亚
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测
      • 韩国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测
      • 其他亚太地区
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测
  • 拉丁美洲/中东/非洲
    • 主要趋势和机会
    • 市场规模和按类型预测
    • 市场规模和移动性预测
    • 各组成部分的市场规模和预测
    • 市场规模和应用预测
    • 市场规模和预测：按国家/地区分类
      • 巴西
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测
      • 沙特阿拉伯
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测
      • 南非
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测
      • 其他拉丁美洲/中东/非洲
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和移动性预测
      • 各组成部分的市场规模和预测
      • 市场规模和应用预测

第9章竞争格局

  • 介绍
  • 关键成功策略
  • 排名前 10 位的玩家产品映射
  • 比赛仪表板
  • 竞争热图
  • 顶级玩家定位，2021

第十章公司简介

  • CYBERDYNE INC.
  • Ekso Bionics
  • Ergosante
  • B-Temia
  • ExoAtlet
  • Rewalk Robotics
  • Ottobock SE & Co. KGaA（suit X）
  • Human Motion Technologies LLC
  • Wearable Robotics srl
  • DIH Medical
Product Code: A11183

The global medical exoskeleton market was valued at $232.5 million in 2021, and is projected to reach $3,044.7 million by 2031, growing at a CAGR of 29.4% from 2022 to 2031.Medical exoskeleton is a wearable electromechanical device that has been developed as external framework that is worn in the body to help patient recover from an injury and to enhance the biological capabilities such as orthotic devices for gait rehabilitation or locomotion assistance. Therefore, this frame offers limbs extra movement, strength, and endurance. Medical exoskeletons are used to power disabled, injured, or vulnerable people suffering from a variety of medical conditions such as spinal cord injury (SCI), neuropathy, major trauma such as stroke, and cerebral palsy. These medical exoskeletons are typically used in monitored settings such as hospitals and rehab centers under the supervision of medical professionals.

The growth of the medical exoskeleton market is driven by technological advancement for development of different medical exoskeleton devices, and rise in prevalence of spinal cord injuries, neurological disorders such as multiple sclerosis, Parkinson's disease, and others. In addition, increase in number of people suffering from disability is anticipated to fuel the demand for medical exoskeleton and is anticipated to drive the growth of the market. For instance, according to World Health Organization (WHO), in December 2022, it was reported that, an estimated 1.3 billion people - or 16% of the global population experience a significant disability. This number is growing because of an increase prevalence of neurological disorders and rise in number of geriatric populations. Moreover, rise in number of people suffering from spinal cord injuries, neurological disorders such as multiple sclerosis, Parkinson's disease and others is attributed to increase the demand for medical exoskeleton devices and boosts the market growth. For instance, according to National Spinal Cord Injury Model Systems Database (NSCMSD), in June 2022, it was reported that, approximately 51000 people are suffering from spinal cord injury.

In addition, rise in prevalence of neurological disorders such as multiple sclerosis, Parkinson's disease and stroke are anticipated to drive the demand for medical exoskeleton devices and fuels the market growth. For instance, according to National Multiple Sclerosis Society, it was reported that, in September 2020, approximately 2.8 million people worldwide are suffering from multiple sclerosis (MS). As per the same source, it was reported that, nearly 1 million of them are living in the U.S. in 2020.

Moreover, rise in healthcare expenditure, increase in disposable income, and expansion of middle-class population in developing countries are expected to create lucrative growth opportunities to drive the growth of the medical exoskeleton market. In addition, geriatric population is susceptible to neurological disorders and orthopedic diseases. Thus, rise in number of geriatric population is anticipated to fuel the demand for medical exoskeleton devices and drive the market growth. For instance, according to Population Reference Bureau, in 2019, regions such as Asia and Europe are home to some of the world's oldest populations, those ages 65 and above. Top countries include Japan at 28%, followed by Italy at 23%. Finland, Portugal, and Greece round out the top five at just under 22%.

Moreover, rise in expenditure by government to develop healthcare infrastructure fuels the market growth. For instance, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.0% of the gross domestic product (GDP) in 2020, as compared to 9.9% in 2019. Furthermore, it has been estimated that 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment and application used at public health centers, such as hospitals. Hence, rise in healthcare expenditure across the globe is expected to fuel the demand for medical exoskeleton application in disabled population, thereby boosting the market growth.

On the other hand, high cost of medical exoskeleton devices and safety concern for devices are some factors that are anticipated to restrain the growth of the medical exoskeleton market.

The medical exoskeleton market is segmented into type, component, mobility, and application. Based on type, the market is divided into powered exoskeleton and passive exoskeleton. Based on component, the market is divided into hardware and software. Based on mobility, the market is bifurcated into stationary and mobile. Based on application, the market is divided into spinal cord injury, stroke, and others. The others segment includes multiple sclerosis, osteoarthritis, Parkinson's disease and acquired brain injuries. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global medical exoskeleton market include: CYBERDYNE INC., Ekso Bionics, Ergosante, B-Temia, ExoAtlet, ReWalk Robotics., Ottobock SE & Co. KGaA (suit X), DIH medical Hocoma., Human Motion Technologies LLC., and Wearable Robotics srl.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the medical exoskeleton market analysis from 2021 to 2031 to identify the prevailing medical exoskeleton market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the medical exoskeleton market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global medical exoskeleton market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Powered exoskeleton
  • Passive exoskeleton

By Mobility

  • Stationary
  • Mobile

By Component

  • Hardware
  • Software

By Application

  • Spinal Cord Injury
  • Stroke
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • CYBERDYNE INC.
  • Ekso Bionics
  • B-Temia
  • Rewalk Robotics
  • Ottobock SE & Co. KGaA (suit X)
  • DIH Medical
  • Ergosante
  • ExoAtlet
  • Human Motion Technologies LLC
  • Wearable Robotics srl

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. High bargaining power of suppliers
    • 3.3.2. Moderate bargaining power of buyers
    • 3.3.3. High threat of substitutes
    • 3.3.4. High threat of new entrants
    • 3.3.5. High intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in the prevalence of neurological disorders.
      • 3.4.1.2. Increase in the number of spinal cord injuries and brain injuries.
      • 3.4.1.3. Rise in the number of geriatric populations.
    • 3.4.2. Restraints
      • 3.4.2.1. Regulatory challenges for securing approvals for medical applications of exoskeletons.
    • 3.4.3. Opportunities
      • 3.4.3.1. Increase in the number of product approvals by market players.
      • 3.4.3.2. Rise in the number of adoptions of key strategies by market players
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: MEDICAL EXOSKELETON MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Powered exoskeleton
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Passive exoskeleton
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: MEDICAL EXOSKELETON MARKET, BY MOBILITY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Stationary
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Mobile
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: MEDICAL EXOSKELETON MARKET, BY COMPONENT

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hardware
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Software
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: MEDICAL EXOSKELETON MARKET, BY APPLICATION

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Spinal Cord Injury
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Stroke
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Others
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country

CHAPTER 8: MEDICAL EXOSKELETON MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key trends and opportunities
    • 8.2.2. Market size and forecast, by Type
    • 8.2.3. Market size and forecast, by Mobility
    • 8.2.4. Market size and forecast, by Component
    • 8.2.5. Market size and forecast, by Application
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Key market trends, growth factors and opportunities
      • 8.2.6.1.2. Market size and forecast, by Type
      • 8.2.6.1.3. Market size and forecast, by Mobility
      • 8.2.6.1.4. Market size and forecast, by Component
      • 8.2.6.1.5. Market size and forecast, by Application
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Key market trends, growth factors and opportunities
      • 8.2.6.2.2. Market size and forecast, by Type
      • 8.2.6.2.3. Market size and forecast, by Mobility
      • 8.2.6.2.4. Market size and forecast, by Component
      • 8.2.6.2.5. Market size and forecast, by Application
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Key market trends, growth factors and opportunities
      • 8.2.6.3.2. Market size and forecast, by Type
      • 8.2.6.3.3. Market size and forecast, by Mobility
      • 8.2.6.3.4. Market size and forecast, by Component
      • 8.2.6.3.5. Market size and forecast, by Application
  • 8.3. Europe
    • 8.3.1. Key trends and opportunities
    • 8.3.2. Market size and forecast, by Type
    • 8.3.3. Market size and forecast, by Mobility
    • 8.3.4. Market size and forecast, by Component
    • 8.3.5. Market size and forecast, by Application
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Key market trends, growth factors and opportunities
      • 8.3.6.1.2. Market size and forecast, by Type
      • 8.3.6.1.3. Market size and forecast, by Mobility
      • 8.3.6.1.4. Market size and forecast, by Component
      • 8.3.6.1.5. Market size and forecast, by Application
      • 8.3.6.2. France
      • 8.3.6.2.1. Key market trends, growth factors and opportunities
      • 8.3.6.2.2. Market size and forecast, by Type
      • 8.3.6.2.3. Market size and forecast, by Mobility
      • 8.3.6.2.4. Market size and forecast, by Component
      • 8.3.6.2.5. Market size and forecast, by Application
      • 8.3.6.3. UK
      • 8.3.6.3.1. Key market trends, growth factors and opportunities
      • 8.3.6.3.2. Market size and forecast, by Type
      • 8.3.6.3.3. Market size and forecast, by Mobility
      • 8.3.6.3.4. Market size and forecast, by Component
      • 8.3.6.3.5. Market size and forecast, by Application
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Key market trends, growth factors and opportunities
      • 8.3.6.4.2. Market size and forecast, by Type
      • 8.3.6.4.3. Market size and forecast, by Mobility
      • 8.3.6.4.4. Market size and forecast, by Component
      • 8.3.6.4.5. Market size and forecast, by Application
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Key market trends, growth factors and opportunities
      • 8.3.6.5.2. Market size and forecast, by Type
      • 8.3.6.5.3. Market size and forecast, by Mobility
      • 8.3.6.5.4. Market size and forecast, by Component
      • 8.3.6.5.5. Market size and forecast, by Application
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Key market trends, growth factors and opportunities
      • 8.3.6.6.2. Market size and forecast, by Type
      • 8.3.6.6.3. Market size and forecast, by Mobility
      • 8.3.6.6.4. Market size and forecast, by Component
      • 8.3.6.6.5. Market size and forecast, by Application
  • 8.4. Asia-Pacific
    • 8.4.1. Key trends and opportunities
    • 8.4.2. Market size and forecast, by Type
    • 8.4.3. Market size and forecast, by Mobility
    • 8.4.4. Market size and forecast, by Component
    • 8.4.5. Market size and forecast, by Application
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. Japan
      • 8.4.6.1.1. Key market trends, growth factors and opportunities
      • 8.4.6.1.2. Market size and forecast, by Type
      • 8.4.6.1.3. Market size and forecast, by Mobility
      • 8.4.6.1.4. Market size and forecast, by Component
      • 8.4.6.1.5. Market size and forecast, by Application
      • 8.4.6.2. China
      • 8.4.6.2.1. Key market trends, growth factors and opportunities
      • 8.4.6.2.2. Market size and forecast, by Type
      • 8.4.6.2.3. Market size and forecast, by Mobility
      • 8.4.6.2.4. Market size and forecast, by Component
      • 8.4.6.2.5. Market size and forecast, by Application
      • 8.4.6.3. India
      • 8.4.6.3.1. Key market trends, growth factors and opportunities
      • 8.4.6.3.2. Market size and forecast, by Type
      • 8.4.6.3.3. Market size and forecast, by Mobility
      • 8.4.6.3.4. Market size and forecast, by Component
      • 8.4.6.3.5. Market size and forecast, by Application
      • 8.4.6.4. Australia
      • 8.4.6.4.1. Key market trends, growth factors and opportunities
      • 8.4.6.4.2. Market size and forecast, by Type
      • 8.4.6.4.3. Market size and forecast, by Mobility
      • 8.4.6.4.4. Market size and forecast, by Component
      • 8.4.6.4.5. Market size and forecast, by Application
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Key market trends, growth factors and opportunities
      • 8.4.6.5.2. Market size and forecast, by Type
      • 8.4.6.5.3. Market size and forecast, by Mobility
      • 8.4.6.5.4. Market size and forecast, by Component
      • 8.4.6.5.5. Market size and forecast, by Application
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Key market trends, growth factors and opportunities
      • 8.4.6.6.2. Market size and forecast, by Type
      • 8.4.6.6.3. Market size and forecast, by Mobility
      • 8.4.6.6.4. Market size and forecast, by Component
      • 8.4.6.6.5. Market size and forecast, by Application
  • 8.5. LAMEA
    • 8.5.1. Key trends and opportunities
    • 8.5.2. Market size and forecast, by Type
    • 8.5.3. Market size and forecast, by Mobility
    • 8.5.4. Market size and forecast, by Component
    • 8.5.5. Market size and forecast, by Application
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Key market trends, growth factors and opportunities
      • 8.5.6.1.2. Market size and forecast, by Type
      • 8.5.6.1.3. Market size and forecast, by Mobility
      • 8.5.6.1.4. Market size and forecast, by Component
      • 8.5.6.1.5. Market size and forecast, by Application
      • 8.5.6.2. Saudi Arabia
      • 8.5.6.2.1. Key market trends, growth factors and opportunities
      • 8.5.6.2.2. Market size and forecast, by Type
      • 8.5.6.2.3. Market size and forecast, by Mobility
      • 8.5.6.2.4. Market size and forecast, by Component
      • 8.5.6.2.5. Market size and forecast, by Application
      • 8.5.6.3. South Africa
      • 8.5.6.3.1. Key market trends, growth factors and opportunities
      • 8.5.6.3.2. Market size and forecast, by Type
      • 8.5.6.3.3. Market size and forecast, by Mobility
      • 8.5.6.3.4. Market size and forecast, by Component
      • 8.5.6.3.5. Market size and forecast, by Application
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Key market trends, growth factors and opportunities
      • 8.5.6.4.2. Market size and forecast, by Type
      • 8.5.6.4.3. Market size and forecast, by Mobility
      • 8.5.6.4.4. Market size and forecast, by Component
      • 8.5.6.4.5. Market size and forecast, by Application

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top player positioning, 2021

CHAPTER 10: COMPANY PROFILES

  • 10.1. CYBERDYNE INC.
    • 10.1.1. Company overview
    • 10.1.2. Key Executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Business performance
    • 10.1.7. Key strategic moves and developments
  • 10.2. Ekso Bionics
    • 10.2.1. Company overview
    • 10.2.2. Key Executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
    • 10.2.6. Business performance
    • 10.2.7. Key strategic moves and developments
  • 10.3. Ergosante
    • 10.3.1. Company overview
    • 10.3.2. Key Executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
  • 10.4. B-Temia
    • 10.4.1. Company overview
    • 10.4.2. Key Executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
    • 10.4.6. Key strategic moves and developments
  • 10.5. ExoAtlet
    • 10.5.1. Company overview
    • 10.5.2. Key Executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
  • 10.6. Rewalk Robotics
    • 10.6.1. Company overview
    • 10.6.2. Key Executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
    • 10.6.6. Business performance
    • 10.6.7. Key strategic moves and developments
  • 10.7. Ottobock SE & Co. KGaA (suit X)
    • 10.7.1. Company overview
    • 10.7.2. Key Executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
  • 10.8. Human Motion Technologies LLC
    • 10.8.1. Company overview
    • 10.8.2. Key Executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
  • 10.9. Wearable Robotics srl
    • 10.9.1. Company overview
    • 10.9.2. Key Executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
  • 10.10. DIH Medical
    • 10.10.1. Company overview
    • 10.10.2. Key Executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 02. MEDICAL EXOSKELETON MARKET FOR POWERED EXOSKELETON, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 03. MEDICAL EXOSKELETON MARKET FOR PASSIVE EXOSKELETON, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 04. GLOBAL MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 05. MEDICAL EXOSKELETON MARKET FOR STATIONARY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 06. MEDICAL EXOSKELETON MARKET FOR MOBILE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 07. GLOBAL MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 08. MEDICAL EXOSKELETON MARKET FOR HARDWARE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 09. MEDICAL EXOSKELETON MARKET FOR SOFTWARE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. GLOBAL MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. MEDICAL EXOSKELETON MARKET FOR SPINAL CORD INJURY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. MEDICAL EXOSKELETON MARKET FOR STROKE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. MEDICAL EXOSKELETON MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. MEDICAL EXOSKELETON MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. U.S. MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. U.S. MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. U.S. MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. U.S. MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. CANADA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. CANADA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. CANADA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. CANADA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. MEXICO MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. MEXICO MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. MEXICO MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. MEXICO MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. EUROPE MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. EUROPE MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. EUROPE MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. EUROPE MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. EUROPE MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. GERMANY MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. GERMANY MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. GERMANY MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. GERMANY MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. FRANCE MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. FRANCE MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. FRANCE MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. FRANCE MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. UK MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. UK MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. UK MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. UK MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. ITALY MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. ITALY MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. ITALY MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. ITALY MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. SPAIN MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. SPAIN MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. SPAIN MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. SPAIN MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. REST OF EUROPE MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. REST OF EUROPE MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. REST OF EUROPE MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. REST OF EUROPE MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. JAPAN MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. JAPAN MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. JAPAN MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. JAPAN MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. CHINA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. CHINA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. CHINA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. CHINA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. INDIA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. INDIA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. INDIA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. INDIA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. AUSTRALIA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. AUSTRALIA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. AUSTRALIA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. AUSTRALIA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. SOUTH KOREA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. SOUTH KOREA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. SOUTH KOREA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. SOUTH KOREA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 88. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 89. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 90. LAMEA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 91. LAMEA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 92. LAMEA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 93. LAMEA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 94. LAMEA MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 95. BRAZIL MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 96. BRAZIL MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 97. BRAZIL MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 98. BRAZIL MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 99. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 100. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 101. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 102. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 103. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 104. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 105. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 106. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 107. REST OF LAMEA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 108. REST OF LAMEA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 109. REST OF LAMEA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 110. REST OF LAMEA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 111. CYBERDYNE INC.: KEY EXECUTIVES
  • TABLE 112. CYBERDYNE INC.: COMPANY SNAPSHOT
  • TABLE 113. CYBERDYNE INC.: PRODUCT SEGMENTS
  • TABLE 114. CYBERDYNE INC.: PRODUCT PORTFOLIO
  • TABLE 115. CYBERDYNE INC.: KEY STRATERGIES
  • TABLE 116. EKSO BIONICS: KEY EXECUTIVES
  • TABLE 117. EKSO BIONICS: COMPANY SNAPSHOT
  • TABLE 118. EKSO BIONICS: PRODUCT SEGMENTS
  • TABLE 119. EKSO BIONICS: PRODUCT PORTFOLIO
  • TABLE 120. EKSO BIONICS: KEY STRATERGIES
  • TABLE 121. ERGOSANTE: KEY EXECUTIVES
  • TABLE 122. ERGOSANTE: COMPANY SNAPSHOT
  • TABLE 123. ERGOSANTE: PRODUCT SEGMENTS
  • TABLE 124. ERGOSANTE: PRODUCT PORTFOLIO
  • TABLE 125. B-TEMIA: KEY EXECUTIVES
  • TABLE 126. B-TEMIA: COMPANY SNAPSHOT
  • TABLE 127. B-TEMIA: PRODUCT SEGMENTS
  • TABLE 128. B-TEMIA: PRODUCT PORTFOLIO
  • TABLE 129. B-TEMIA: KEY STRATERGIES
  • TABLE 130. EXOATLET: KEY EXECUTIVES
  • TABLE 131. EXOATLET: COMPANY SNAPSHOT
  • TABLE 132. EXOATLET: PRODUCT SEGMENTS
  • TABLE 133. EXOATLET: PRODUCT PORTFOLIO
  • TABLE 134. REWALK ROBOTICS: KEY EXECUTIVES
  • TABLE 135. REWALK ROBOTICS: COMPANY SNAPSHOT
  • TABLE 136. REWALK ROBOTICS: PRODUCT SEGMENTS
  • TABLE 137. REWALK ROBOTICS: PRODUCT PORTFOLIO
  • TABLE 138. REWALK ROBOTICS: KEY STRATERGIES
  • TABLE 139. OTTOBOCK SE & CO. KGAA (SUIT X): KEY EXECUTIVES
  • TABLE 140. OTTOBOCK SE & CO. KGAA (SUIT X): COMPANY SNAPSHOT
  • TABLE 141. OTTOBOCK SE & CO. KGAA (SUIT X): PRODUCT SEGMENTS
  • TABLE 142. OTTOBOCK SE & CO. KGAA (SUIT X): PRODUCT PORTFOLIO
  • TABLE 143. HUMAN MOTION TECHNOLOGIES LLC: KEY EXECUTIVES
  • TABLE 144. HUMAN MOTION TECHNOLOGIES LLC: COMPANY SNAPSHOT
  • TABLE 145. HUMAN MOTION TECHNOLOGIES LLC: PRODUCT SEGMENTS
  • TABLE 146. HUMAN MOTION TECHNOLOGIES LLC: PRODUCT PORTFOLIO
  • TABLE 147. WEARABLE ROBOTICS SRL: KEY EXECUTIVES
  • TABLE 148. WEARABLE ROBOTICS SRL: COMPANY SNAPSHOT
  • TABLE 149. WEARABLE ROBOTICS SRL: PRODUCT SEGMENTS
  • TABLE 150. WEARABLE ROBOTICS SRL: PRODUCT PORTFOLIO
  • TABLE 151. DIH MEDICAL: KEY EXECUTIVES
  • TABLE 152. DIH MEDICAL: COMPANY SNAPSHOT
  • TABLE 153. DIH MEDICAL: PRODUCT SEGMENTS
  • TABLE 154. DIH MEDICAL: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. MEDICAL EXOSKELETON MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF MEDICAL EXOSKELETON MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN MEDICAL EXOSKELETON MARKET (2022-2031)
  • FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06. HIGH THREAT OF SUBSTITUTES
  • FIGURE 07. HIGH THREAT OF NEW ENTRANTS
  • FIGURE 08. HIGH INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALMEDICAL EXOSKELETON MARKET
  • FIGURE 10. MEDICAL EXOSKELETON MARKET, BY TYPE, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR POWERED EXOSKELETON, BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR PASSIVE EXOSKELETON, BY COUNTRY 2021-2031(%)
  • FIGURE 13. MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR STATIONARY, BY COUNTRY 2021-2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR MOBILE, BY COUNTRY 2021-2031(%)
  • FIGURE 16. MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR HARDWARE, BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR SOFTWARE, BY COUNTRY 2021-2031(%)
  • FIGURE 19. MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR SPINAL CORD INJURY, BY COUNTRY 2021-2031(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR STROKE, BY COUNTRY 2021-2031(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 23. MEDICAL EXOSKELETON MARKET BY REGION, 2021
  • FIGURE 24. U.S. MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 25. CANADA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 26. MEXICO MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. GERMANY MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. FRANCE MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. UK MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. ITALY MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. SPAIN MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. REST OF EUROPE MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. JAPAN MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. CHINA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. INDIA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. AUSTRALIA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. SOUTH KOREA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. BRAZIL MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. REST OF LAMEA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47. COMPETITIVE DASHBOARD
  • FIGURE 48. COMPETITIVE HEATMAP: MEDICAL EXOSKELETON MARKET
  • FIGURE 49. TOP PLAYER POSITIONING, 2021
  • FIGURE 50. CYBERDYNE INC.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 51. CYBERDYNE INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 52. EKSO BIONICS: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 53. EKSO BIONICS: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 54. EKSO BIONICS: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 55. EKSO BIONICS: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 56. REWALK ROBOTICS: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 57. REWALK ROBOTICS: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 58. REWALK ROBOTICS: REVENUE SHARE BY REGION, 2021 (%)